FDA Takes Hard Look at CBD
CBD products have swamped the market due to change in federal law, not because of new medical evidence
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
Guidelines Issued for Addressing Heart Disease Risk in HIV
Individuals with HIV have significantly higher rates of CVD, may have underuse of statins, antithrombotics
Number, Rate of Detergent Pod Exposures Modestly Declined
Increases seen from 2012 to 2015 in children <6, but 18 percent decrease observed 2015 to 2017
Gout Linked to Increased Risk for Venous Thromboembolism
Venous thromboembolism risk similar for patients with gout regardless of urate-lowering therapy
Pressure Injuries at Time of ICU Admission Tied to Longer Stays
Pressure injuries also may have modest association with higher risk for mortality
Current Strategies for Measles Vaccination Insufficient
Current policies will not eliminate measles or prevent future resurgence in seven high-income countries
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity
Higher Surgical Volume May Improve Outcomes in Cervical Cancer
Findings show radical hysterectomy at high-volume centers tied to better survival in early cervical cancer
May 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for May 2019. This roundup includes the latest...
